Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hashemi, Seyed Mahmoud  [Clear All Filters]
2022
Khosrowpour Z, Hashemi SMahmoud, Mohammadi-Yeganeh S, Moghtadaei M, Milan PBrouki, Moroni L, Kundu SC, Gholipourmalekabadi M. Coculture of adipose-derived mesenchymal stem cells/macrophages on decellularized placental sponge promotes differentiation into the osteogenic lineage. Artif Organs. 2022.
Asadirad A, Baghaei K, Hashemi SMahmoud, Dehnavi S, Ghanbarian H, Mortaz E, Anissian A, Aghdaei HAsadzadeh, Amani D. Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line. Int Immunopharmacol. 2022;104:108493.
Hazrati A, Malekpour K, Soudi S, Hashemi SMahmoud. Mesenchymal stromal/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: A new strategy to overcome cell therapy limitations. Biomed Pharmacother. 2022;152:113211.
Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei K, Zali MReza, Mirsanei Z, Hashemi SMahmoud. Regulation of the Th17/Treg balance by human umbilical cord mesenchymal stem cell-derived exosomes protects against acute experimental colitis. Exp Cell Res. 2022:113296.
Eshghi F, Tahmasebi S, Alimohammadi M, Soudi S, Khaligh SGhaffari, Khosrojerdi A, Heidari N, Hashemi SMahmoud. Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in mouse model of LPS induced systemic inflammation. Life Sci. 2022:120938.
2020
Taghavi-Farahabadi M, Mahmoudi M, Hashemi SMahmoud, Rezaei N. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. Int Immunopharmacol. 2020;83:106463.
Salimi M, Shirazi A, Norouzian M, Mehrazar MMehdi, Naderi MMehdi, Shokrgozar MAli, Omrani M, Hashemi SMahmoud. Histone Modifications of H3K4me3, H3K9me3 and Lineage Gene Expressions in Chimeric Mouse Embryo. Cell J. 2020;22(1):96-105.
Taghavi-Farahabadi M, Mahmoudi M, Soudi S, Hashemi SMahmoud. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Med Hypotheses. 2020;144:109865.
Mokhberian N, Bolandi Z, Eftekhary M, Hashemi SMahmoud, Jajarmi V, Sharifi K, Ghanbarian H. Inhibition of miR-34a reduces cellular senescence in human adipose tissue-derived mesenchymal stem cells through the activation of SIRT1. Life Sci. 2020:118055.
Fathollahi A, Hashemi SMahmoud, Hoseini MHaji Molla, Tavakoli S, Farahani E, Yeganeh F. Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2020;90:107207.
Sadeghi S, Soudi S, Shafiee A, Hashemi SMahmoud. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action. Life Sci. 2020:118493.
Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad REslami, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SMahmoud, Łos MJ, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol. 2020:173263.

Pages